10 studies found for:    " December 15, 2006":" December 22, 2006"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
1 Completed A Phase I Study of Safety and Immunogenicity of the WRAIR HIV-1 Vaccine LFn-p24 Administered by the Intramuscular (IM) Route in Healthy Adults
Condition: HIV Infections
Intervention: Biological: HIV LFn-p24
2 Completed Safety and Efficacy of a Three-Dose Regimen of an Adenoviral HIV Vaccine (MRKAd5 HIV-1 Gag/Pol/Nef) in HIV Uninfected South African Adults
Condition: HIV Infections
Interventions: Biological: MRKAd5 HIV-1 gag/pol/nef;   Other: Placebo
3 Withdrawn Safety of and Immune Response to an HIV DNA Plasmid Vaccine Followed by HIV Adenoviral Vector Vaccine in Healthy African Adults
Condition: HIV Infections
Interventions: Biological: VRC-HIVDNA016-00-VP;   Biological: VRC-HIVADV014-00-VP;   Biological: Vaccine placebo
4 Completed A RCT of Prednisone as Adjunctive Therapy for Hospitalized Patients With Pulmonary TB and HIV Co-infection
Conditions: Tuberculosis;   HIV Infections
Interventions: Drug: Prednisone;   Drug: placebo
5 Completed
Has Results
Metabolic Effects of Switching Kaletra to Boosted Reyataz
Condition: HIV Infections
Interventions: Drug: atazanavir/ritonavir;   Drug: lopinavir/ritonavir
6 Completed Study to Evaluate the Replacement of Reverse Transcriptase Nucleoside/Nucleotide Inhibitors by Nevirapine in Patients on Triple Treatment With Analogues Only
Condition: HIV Infections
Intervention: Drug: Nevirapine
7 Completed
Has Results
FOTO: Five Consecutive Days on Treatment With Efavirenz, Tenofovir, and Emtricitabine Followed by Two Days Off Treatment Versus Continuous Treatment
Condition: HIV Infections
Interventions: Drug: efavirenz;   Drug: tenofovir;   Drug: emtricitabine
8 Terminated BOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r)
Condition: HIV Infections
Intervention: Drug: Increased dose of Kaletra
9 Completed
Has Results
Safety and Effectiveness of Short-Term Anti-HIV Drug Therapy for Recent HIV-1 Infection
Condition: HIV Infections
Interventions: Drug: Tenofovir disoproxil fumarate/Emtricitabine;   Drug: Lopinavir/Ritonavir
10 Completed TMC125-C203: Phase II Randomized (Patients Are Assigned Different Treatments Based on Chance), Placebo Controlled Dose Escalating Trial of TMC125 in HIV-1 Infected Patients
Conditions: Anti-Retroviral Agents;   HIV-1
Intervention: Drug: TMC125

Indicates status has not been verified in more than two years